Pricing

First Wave BioPharma Inc (FWBI)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
James E. Sapirstein
Employees:
20
777 YAMATO ROAD, SUITE 502, BOCA RATON, FL, 33431
561-589-7020
Stock Split History
DateRatio
2021-09-13 1:10
2022-08-26 1:30
2023-01-18 1:7
2023-12-18 1:20
First Wave BioPharma, Inc. engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties; and the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available